A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
AbstractBackground Hepatocellular carcinoma lacks ideal diagnostic biomarkers. There is a lack of scientific evaluation of relevant promising biomarkers as well. Therefore this study reanalyzes the related studies of 11 blood biomarkers of HCC, and compares the diagnostic value of these biomarkers f...
Main Authors: | Bing-yao Pang, Yan Leng, Xiaoli Wang, Yi-qiang Wang, Li-hong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2022.2153163 |
Similar Items
-
Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma
by: Ren-chao Zou, et al.
Published: (2019-12-01) -
Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis
by: Xu Zhang, et al.
Published: (2023-03-01) -
Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
by: Yasi Pan, et al.
Published: (2020-12-01) -
Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma
by: Man Wang, et al.
Published: (2018-08-01) -
Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals
by: Devis Pascut, et al.
Published: (2019-11-01)